Articles From: Prospect Capital Provides $215 Million of First Lien Senior Secured Credit Facilities to Pacific World Corporation, a Portfolio Company of Levine Leichtman Capital Partners to JetBlue and EL AL Israel Airlines Announce Plans to Codeshare


http://media.marketwire.com/attachments/200805/430382_ProspectCapitalLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147678&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Prospect Capital Provides $215 Million of First Lien Senior Secured Credit Facilities to Pacific World Corporation, a Portfolio Company of Levine Leichtman Capital Partners investment picks
Rudolph Technologies, Inc. (NYSE: RTEC) announced today that Michael Plisinski, vice president and general manager of the Company’s Data Analysis and Review Business Unit has been appointed executive vice president and chief operating officer (COO) effective October 1, 2014.
Sign-up for Rudolph Technologies Appoints Michael Plisinski as Chief Operating Officer investment picks
Development Kit Features Two FPGA Mezzanine Card Headers for Off-the-shelf Daughter Cards and Comes with Complimentary Libero Platinum Development License ALISO VIEJO, Calif.
Sign-up for Microsemi Expands Customer Application Design Opportunities by Introducing SmartFusion2 Advanced Development Kit with Largest Density 150K LE Device investment picks
http://media.marketwire.com/attachments/201305/60668_insys.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147673&ProfileId=051205&sourceType=1 PHOENIX, AZ --
Sign-up for Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioma investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0970227001&sourceType=1 http://media3.marketwire.com/logos/20130605-RioAlto.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Rio Alto Completes 2014 Oxide Drilling Program at La Arena investment picks
IRVINE, Calif., Sept.
Sign-up for Endologix Completes Enrollment in EVAS FORWARD - Global Registry investment picks
LEOPARD Study to Enroll 600 Patients to Provide a "Real-World" Head-to-Head Comparison of the AFX® System Versus Other Commercially Available EVAR Devices IRVINE, Calif., Sept.
Sign-up for Endologix to Initiate First Ever Comparative Randomized EVAR Study investment picks
Shares of Athlon Energy Inc. (ATHL) surged 24% in premarket action on Monday after news that Canada's Encana Corp.
Sign-up for Athlon shares soar 24% premarket after Encana deal investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that patients with Hodgkin lymphoma (HL) who received ADCETRIS (brentuximab vedotin) as consolidation therapy immediately following an autologous stem cell transplantation (ASCT) lived significantly longer without disease progression compared to patients who received placebo.
Sign-up for Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA Clinical Trial of ADCETRIS® (Brentuximab Vedotin) for Consolidation in Post-Transplant Hodgkin Lymphoma investment picks
AVEO Oncology (NASDAQ:AVEO) today announced poster presentations for two Phase 2 clinical studies of tivozanib, one in metastatic colorectal cancer (mCRC) and one in renal cell carcinoma (RCC), at the 2014 Congress of the European Society for Medical Oncology (ESMO), taking place September 25–30 in Madrid, Spain.
Sign-up for AVEO Oncology Announces Results from Phase 2 Clinical Studies of Tivozanib in Patients with Advanced Colorectal and Kidney Cancers Presented at ESMO 2014 Congress investment picks
IRVINE, Calif., Sept.
Sign-up for Sabra Health Care REIT Announces Public Offering of 6,000,000 Shares of Common Stock investment picks
HIGHLIGHTS Consists of 21 independent living facilities, 100% private pay 2,850 units located in 15 states 7.14% GAAP lease yield Annual rent escalators of 4.0% in years 2 and 3, the greater of CPI and 3.5% thereafter Credit enhancement from substantial guarantor entity including fixed charge coverage and other covenants This acquisition creates a significant shift in our portfolio composition and increases our total annualized revenues by 23.0% (pro forma as of June 30, 2014): IRVINE, Calif., Sept.
Sign-up for Sabra Acquires Portfolio of 21 Independent Living Facilities in Sale/Leaseback Transaction From Affiliates of Holiday Retirement investment picks
Cal-Maine Foods, Inc. (NASDAQ: CALM) today announced results for the first quarter of fiscal 2015 ended August 30, 2014.
Sign-up for Cal-Maine Foods Reports First Quarter Fiscal 2015 Results investment picks
Unwired Planet, Inc. (NASDAQ:UPIP), today announced that Eric Vetter intends to resign as the company’s president, chief financial officer and chief administrative officer as of November 18, 2014.
Sign-up for Unwired Planet Announces Management Transition Plan investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0970237001&sourceType=1 http://media3.marketwire.com/logos/20130625-serinus_logo_update_200.jpg CALGARY, ALBERTA --
Sign-up for Serinus Energy Inc.-Ukraine: Impact of New Ukrainian Banking Regulations investment picks
MCLEAN, Va.
Sign-up for CYREN Named to Deloitte 2014 Israel Technology Fast 50 investment picks
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that positive initial data from the ongoing, open label Phase II clinical trial of its investigational drug PB272 (neratinib) for the treatment of patients with non-small cell lung cancer (NSCLC) with HER2 mutations was presented today as a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) 2014 Congress, taking place in Madrid, Spain.
Sign-up for Puma Biotechnology Announces Positive Initial Results from PB272 Phase II Trial in HER2 Mutated Non-Small Cell Lung Cancer investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics Announces Approval of Its AXP(R) AutoXpress(R) System in Taiwan investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics Reports Fourth Quarter and Full Fiscal 2014 Results investment picks
Conference Call to Discuss Results at 8:00 a.m. EDT on September 29, 2014 Dial-in Numbers Below BEIJING , Sept.
Sign-up for Lentuo International Reports Second Quarter 2014 Financial Results investment picks
AVEO Oncology (NASDAQ:AVEO) and Biodesix, Inc. today announced the presentation of results from a retrospective exploratory analysis using VeriStrat®, a commercially available serum protein test, to identify patients most likely to benefit from the addition of ficlatuzumab, AVEO’s HGF inhibitory antibody, to epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitor (TKI) therapy in a randomized Phase 2 study of ficlatuzumab and gefitinib (IRESSA®) in previously untreated Asian subjects with non-small cell lung cancer (NSCLC). The results, presented in a poster session (abstract #8195) at the 2014 Congress of the European Society for Medical Oncology (ESMO), suggest that VeriStrat may be selective of positive clinical response for ficlatuzumab plus gefitinib over gefitinib alone.
Sign-up for AVEO and Biodesix Announce Exploratory Analysis of VeriStrat-Selected Patients with Non-Small Cell Lung Cancer in Phase 2 Study of Ficlatuzumab Presented at ESMO 2014 Congress investment picks
Cadence to supply critical IP and tools for advanced low power mobile and consumer applications SAN JOSE, Calif.
Sign-up for Cadence IP Portfolio and Tools to Support New TSMC Ultra-Low Power Technology Platform investment picks
Board Completes Assessment of Structural Alternatives; Determines C-Corp Structure Best Positions Company for Sustainable Shareholder Value Creation HOUSTON, Sept.
Sign-up for Civeo to Continue as a C Corporation and Redomicile to Canada investment picks
THE WOODLANDS, Texas , Sept.
Sign-up for Huntsman Announces 400 Ktes MDI Expansion Plan for US Manufacturing Plant investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G022658-001&sourceType=1 NEW YORK, NY and TEL AVIV, ISRAEL--(Marketwired - September 29, 2014) - EL AL Israel Airlines and JetBlue Airways (NASDAQ: JBLU) today filed with the United States Department of Transportation seeking approval to codeshare.
Sign-up for JetBlue and EL AL Israel Airlines Announce Plans to Codeshare investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Prospect Capital Provides $215 Million of First Lien Senior Secured Credit Facilities to Pacific World Corporation, a Portfolio Company of Levine Leichtman Capital Partners to JetBlue and EL AL Israel Airlines Announce Plans to Codeshare
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices